Figure 3.

Boxplot of the delta change in insulin sensitivity (M LBM/I by group: Chromium therapy group is divided into high serum chromium group (>3.1 μg/L); low serum chromium group (≤ 3.1 μg/L); and placebo group. High serum chromium group had had greater insulin resistance than participants in the low serum chromium group or the placebo group, p=0.02, p=0.05 respectively.

Masharani et al. BMC Endocrine Disorders 2012 12:31   doi:10.1186/1472-6823-12-31
Download authors' original image